A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Zespri raises profit guidance, fruit forecasts
Primary Sector

Zespri raises profit guidance, fruit forecasts

Growers are voting on expanding the co-op's overseas supply.

Riley Kennedy 21 Nov 2024
Mānuka Health returns to profit
Primary Sector

Mānuka Health returns to profit

The mānuka honey company reported an NPAT of $4m for the 2024 year.

Staff reporters 21 Nov 2024
Yashili blames group structural changes for late accounts filing
Primary Sector

Yashili blames group structural changes for late accounts filing

It's also just been slapped with a penalty by the OIO.

Riley Kennedy 21 Nov 2024